Outcome of community onset severe sepsis, Sepsis-3 sepsis, and bacteremia in Sweden - a prospective population based study.
Ljungström, L.; Andersson, R.; Jacobsson, G.
Show abstract
BackgroundRegister-based studies are common in sepsis epidemiology. Chart review is considered gold standard but is time consuming. This is one of few such studies. MethodsIn a 9-month prospective and consecutive study conducted in 2011-12, chart review was used to investigate outcomes in patients with severe sepsis, Sepsis-3 sepsis, and bacteremia in a population of 256,700 inhabitants in southwest Sweden. All adult patients aged [≥]18 years admitted to hospital and given intravenous antibiotic treatment within 48 hours were evaluated, N=2,196. Cohort mortality was calculated up to 10 years after admission. ResultsAmong 2,072 adults with any infection, 429 patients had severe sepsis of which 59 had septic shock. The 28-day case fatality rate (CFR) was 25%, 41% in those with septic shock. Sepsis-3 sepsis was diagnosed in 1,299 patients. The 28-day CFR was 12%. Among the 1,299, 393 also had severe sepsis. In 906 patients with Sepsis-3 sepsis but not severe sepsis, the 28-day CFR was 6%. For both sepsis definitions, the 28-day CFR increased 10-fold between the youngest and the oldest age groups. Age >75 years, and renal dysfunction were the strongest independent risk factors for 28-day case fatality. Bacteremia occurred in 283/2,072 (13%) patients. The 28-day CFR was 13% overall, 25% in severe sepsis and 4% in non-severe sepsis. Even 10 years after admission, the mortality rate was higher in sepsis patients by either definition. ConclusionsThe 28-day case fatality rate (CFR) in patients with Sepsis-3 sepsis, 12%, is the result of a large group of patients with a low 28-day CFR, 6%, camouflaging a group with severe sepsis and a high 28-day CFR, 25%. Age >75 years is an independent risk factor for case fatality. The 28-day CFR in patients with bacteremia is a function of severe sepsis, not bacteremia per se. Even after ten years, mortality is increased in both sepsis groups.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Clustering ICU patients with sepsis based on the patterns of their circulating biomarkers: a secondary analysis of the CAPTAIN prospective multicenter cohort study 96%
- Application of the Sepsis-3 criteria to describe sepsis epidemiology in the AmsterdamUMCdb intensive care dataset 96%
- Does the Antisecretory Peptide AF-16 modulate fluid balance and inflammation in experimental peritonitis induced sepsis? 94%
Similar papers in this journal
- Calprotectin as a sepsis diagnostic marker in critical care: a retrospective observational study 97%
- COMPARISON OF sPLA2-IIA PERFORMANCE WITH HIGH-SENSITIVE CRP, NEUTROPHIL PERCENTAGE, PCT AND LACTATE TO IDENTIFY BACTERIAL INFECTION: A PROSPECTIVE STUDY 94%
- Standard blood laboratory results in SARS-CoV-19 positive patients: do they show a typical pattern? 94%
Similar papers in this journal
- Time-Dependent Variation in Immunoparalysis Biomarkers Among Patients with Sepsis and Critical Illness 95%
- Apoptotic cells for therapeutic use in cytokine storm associated with sepsis 95%
- Machine Learning Identifies Complicated Sepsis Trajectory and Subsequent Mortality Based on 20 Genes in Peripheral Blood Immune Cells at 24 Hours post ICU admission 95%
Similar papers in this journal
- Increased LPS levels coexist with systemic inflammation and result in monocyte activation in severe COVID-19 patients 94%
- Ozone therapy for patients with COVID-19 pneumonia: preliminary report of a prospective case-control study 92%
- Plasma zinc status and hyperinflammatory syndrome in hospitalized COVID-19 patients: an observational study 92%
Similar papers in this journal
- Validation of SeptiCyte RAPID to discriminate sepsis from non-infectious systemic inflammation 95%
- Evaluating the Association and Predictability of Complex Medication Regimen Scores with Clinical Outcomes Among the Critically Ill 94%
- Administration of tocilizumab to patients with high concentrations of IL-6 in the course of COVID-19 is associated with a better prognosis 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.